Bioinformatics

Bioinformatics is at the cutting edge of modern life sciences, driving innovation across diagnostics, therapeutics, and personalised medicine. By harnessing biological data and applying computational tools, researchers are uncovering new insights into disease, developing in silico drug discovery platforms, and predicting patient outcomes with unprecedented precision.

Protecting these innovations requires a sophisticated intellectual property strategy that understands both biological complexity and software-driven processes. HGF has a long-standing reputation for IP excellence in life sciences and data-centric technologies, making us ideally placed to support bioinformatics innovators.

Our expertise includes:

  • AI and machine learning models trained on biological data
  • Genomic analysis and personalised medicine platforms
  • Computational biology tools and software pipelines
  • Data integration, visualisation, and analytics systems
  • Expert guidance on patentability of algorithms, databases and diagnostic methods under European patent law
  • Coordinating parallel patent strategies across EP, national and international filing routes

From spinouts leveraging university research to global pharmaceutical companies developing next-generation therapies, we work with a broad range of clients to protect core technologies and support commercial success.

We understand the particular challenges of patenting bioinformatics inventions, from hybrid software/biotech technologies to patentability requirements in software and AI innovations. Our attorneys provide commercially focused IP strategies that align with your R&D roadmap, regulatory environment, and funding goals.

Our integrated approach draws on a wealth of technical and legal knowledge across disciplines, combining life sciences, software, and medical regulation expertise. We offer a full suite of IP protection tools, including patents, trade secrets, copyright, and database rights.

At HGF, we don’t just file patents, we help shape your competitive advantage in a fast-evolving market. Partner with us for IP strategies that secure your position at the forefront of bioinformatics innovation.

Latest updates

Event - 7th - 10th October 2026

HGF Attending AIPPI World Congress 2026

HGF is attending the AIPPI World Congress 2026, taking place in Hamburg from 7-10 October 2026. Bringing together intellectual property professionals from around the world, the annual Congress is one …

Event details

Can foreign manufacturers escape the long arm of the UPC’s jurisdiction?

In the three years since it became operational, the UPC has established itself as a leading forum for pan-European patent litigation, with a number of decisions raising important questions regarding …

Read article

Materials at the Final Frontier: How Engineering Innovations Are Powering the Future of Space

The Hidden Drivers of the Space Economy Space may be the ultimate testing ground for technology, but its success depends on what we build with, not just what we build. …

Read article

Sustainable Technologies in Space: Protecting Innovation for a Greener Frontier

The modern space race is not just about reaching farther. Although it’s exciting to think that one day we might have holidays on other planets, space travel and exploration in …

Read article

Patents Beyond Earth: Do we need a Martian Patent Office? Part 2

As of 2026, our patent offices are all Earth-based, and there is no comprehensive or harmonised framework for patent rights covering outer space as a region. However, there are a …

Read article

Patents Beyond Earth: Is Space a No Man's Land? Part 1

It is well established that the patent system is territorial in nature. If you have an invention you wish to patent, at some point, you are going to have to …

Read article
HGF energy and IP

Fuelling IP: Nuclear Fusion Patents – Is 20 Years Enough?

A patent is often described as providing 20 years of exclusivity. For technologies that take many years to develop, test, license and bring to market, the period of commercially meaningful …

Read article

Miniaturisation and Patentability: Why Scaling Down a Product Is Not Enough to Qualify as a Patentable Invention

Miniaturisation has become a defining trend in modern engineering. From consumer electronics to medical devices, companies constantly strive to make products smaller, lighter, and more portable. This evolution is often …

Read article

Let's talk

If you would like to discuss how HGF could help you, contact one of our bioinformatics specialists.